K. Sharma
Molecular Medicine Reports · 2019
A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Whom K. Sharma trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts K. Sharma overall
Papers from K. Sharma's perspective
Ordered by how strongly the researchers K. Sharma trusts endorse each paper. Same corpus, a different order for every researcher.
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics (Nature reviews. Drug discovery)
- Neuropathology of Alzheimer’s Disease
- Tau-targeting therapies for Alzheimer disease (Nature Reviews Neurology)
- A perspective on multi-target drug discovery and design for complex diseases (Clinical and Translational Medicine)
- Alzheimer's disease: genes, proteins, and therapy. (Physiological Reviews)
- Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. (The Lancet)
- The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
- Multi-target-directed ligands to combat neurodegenerative diseases. (Journal of Medicinal Chemistry)
- QSAR Modeling: Where have you been? Where are you going to?
- The history and future of targeting cyclin-dependent kinases in cancer therapy (Nature reviews. Drug discovery)
Their papers
- Cholinesterase inhibitors as Alzheimer's therapeutics (2019) — 604 citations